Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1984-2-24
|
pubmed:abstractText |
Cefroxadine (CXD), an oral cephalosporin antibiotic was studied in the field of obstetrics and gynecology and the following results were obtained. CXD was orally given to 22 cases at daily dose of 1,500 mg 3 times a day. CXD administration was given to 22 cases in all; 4 with cervicitis, 6 with endometritis, 2 with puerperal fever, 4 with bartholinitis, 5 with adnexitis and 1 with vulvitis, respectively. Overall efficacy rate was 77.3% (17/22) (excellent 4, good 13, fair 5). As for side effects, a slight diarrhea was observed. CXD was considered to be a useful antibiotic in the field of obstetrics and gynecology by above the results.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0368-2781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2549-55
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:6655869-Administration, Oral,
pubmed-meshheading:6655869-Adolescent,
pubmed-meshheading:6655869-Adult,
pubmed-meshheading:6655869-Aged,
pubmed-meshheading:6655869-Bacterial Infections,
pubmed-meshheading:6655869-Cephalosporins,
pubmed-meshheading:6655869-Cephradine,
pubmed-meshheading:6655869-Drug Evaluation,
pubmed-meshheading:6655869-Female,
pubmed-meshheading:6655869-Genital Diseases, Female,
pubmed-meshheading:6655869-Humans,
pubmed-meshheading:6655869-Middle Aged,
pubmed-meshheading:6655869-Pregnancy,
pubmed-meshheading:6655869-Puerperal Infection
|
pubmed:year |
1983
|
pubmed:articleTitle |
[Clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|